Injection Manufacturers
Used as the solvent and diluent base for dry powder injections, small-volume parenterals, and sterile drug reconstitution.
PHARMACEUTICAL MANUFACTURING · HARIDWAR, INDIA
Pure. Sterile. Precise.
India's precision manufacturer of Sterile Water for Injection — engineered to the standards that injectable and syrup manufacturers demand.
5ml – 30mlMulti-volume Range
SIDCUL HaridwarWHO-GMP Zone
Phase 2 ExpansionIn Progress
Our Story
From Proprietorship to Pvt. Ltd. — A Manufacturer Built on Demand
📍 SIDCUL, Haridwar, Uttarakhand
🏭 Active Manufacturing Plant
📈 Production Expansion Underway
Deniel Pharmaceuticals operates a working sterile-manufacturing plant at SIDCUL, Haridwar, producing pharmaceutical-grade Sterile Water for Injection across a full 5ml–30ml volume range. Built first as a proprietorship and now incorporated as a Private Limited company, the business has moved from proving its product to formalising its structure for scale.
That structural shift is a response to a clear signal: client demand has outpaced current production capacity. Rather than ration supply, the company is expanding its lines — a build-out driven by confirmed orders from injectable and syrup manufacturers, not by forecast.
The mission is narrow and deliberate — supply pharmaceutical manufacturers with the purity, consistency, and reliability that injectable formulation makes non-negotiable. One product, done to standard, every batch.
Current Product Line
Sterile Water for Injection
Sterile Water for Injection (SWFI) is the foundational solvent of injectable medicine — a sterile, pyrogen-free, additive-free water used to dissolve and dilute drugs before they enter the bloodstream. For the manufacturers who buy it, purity is not a feature; it is the entire specification. Every vial Deniel ships is made to IP / BP / USP grade.
Syrup Manufacturers
Used in the formulation of aqueous-based oral pharmaceutical syrups requiring pharmaceutical-grade water.
Market Opportunity
A ₹6.02 Lakh Crore Market — And India Is Leading the Charge
₹0L CrGlobal WFI Market by 2035
0%CAGR (2025–2035)
0%Injectable drugs use WFI globally
0New injectable plants in India & China
"India emerges as the fastest-growing country in Asia Pacific for sterile injectable water, propelled by enhanced healthcare access and the rise of contract manufacturing organizations."— Global Market Research, 2024
- 🇮🇳India allocated $1.5B for healthcare infrastructure in 2023.
- 💊50%+ of global generic drug exports originate from India & China.
- 📦Over 42% of new injectable formulations (2024–2025) use sterile water as a key component.
Location Advantage
SIDCUL Haridwar: India's regulated pharmaceutical manufacturing zone, with established supply chains and WHO-GMP-grade infrastructure already in place.
Focused Product
Single-product depth in SWFI — no distraction, full expertise in one of pharma's most essential and non-substitutable raw materials.
Supply Gap Opportunity
Demand has already exceeded current supply capacity. Expansion is a response to proven market pull, not speculation.
Phase 2 Expansion
Beyond Water — A Full Sterile Manufacturing Portfolio
Sterile Water for Injection
- Products
- 5ml · 10ml · 15ml · 20ml · 25ml · 30ml vials
- Market
- Injection & Syrup Manufacturers across India
- Status
- Production expansion in progress
Extended Sterile Product Portfolio
- Products
- All Types of RespulesPrefilled Syringes100ml IV Fluids (Antibiotic Formulations)
- Market
- Domestic + International
- Technology
- State-of-the-art manufacturing line
- Demand Signal
- "Very high demand in domestic and international market"
Investment Case
Why Deniel Pharmaceuticals Is a Strategic Bet
Proven Demand
High client demand has already exceeded current production capacity. Expansion is demand-led, not speculative.
Essential Product
Sterile Water for Injection is a non-discretionary input for injectable pharma. It cannot be substituted.
Regulated Hub
SIDCUL Haridwar is a WHO-GMP compliant industrial zone with pharma-grade infrastructure already in place.
Scalable Model
Phase 2 expansion to respules, prefilled syringes, and IV fluids multiplies addressable market with the same sterile expertise.
Regulatory Tailwind
India's PLI scheme, healthcare infrastructure push, and GMP upgradation programs directly support manufacturers like Deniel.
Growing Export Market
Phase 2 targets international markets where demand for sterile injectable components is growing at 10%+ annually.
Get In Touch
Let's Build Something Vital Together
Whether you're an injection manufacturer seeking a reliable SWFI partner, or an investor looking to participate in India's pharmaceutical growth story — we'd love to hear from you.
📍 SIDCUL, Haridwar, Uttarakhand, India
🕑 Enquiries answered within 1–2 business days
🤝 Injection & syrup manufacturers · investors
Thank you
Your message has been sent. We'll be in touch shortly.